14 drug(s) with this reaction
65,321 total reports
Pain In Extremity has been reported as an adverse reaction across 14 drug(s) manufactured by Abbvie Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 65,321 adverse event reports mention pain in extremity in connection with Abbvie Inc products.
This page provides a breakdown of which Abbvie Inc drugs are most commonly associated with pain in extremity, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Abbvie Inc drugs have pain in extremity listed in their FDA adverse event reports, sorted by report count:
In addition to pain in extremity, the following adverse reactions have been reported across Abbvie Inc's drug portfolio:
14 drug(s) manufactured by Abbvie Inc have pain in extremity listed in their FDA adverse event reports: Humira, ADALIMUMAB, LEVOTHYROXINE SODIUM, UPADACITINIB, FENOFIBRATE, and others.
There are a combined 65,321 reports of pain in extremity across 14 Abbvie Inc drug(s) in the FDA adverse event database.